Brought to you by 
Spectranetics acquires AngioScore
25 Sep 2020
Executive Summary
Spectranetics Corp. (medical devices for use in minimally invasive cardiovascular procedures) acquired AngioScore Inc. (cardiovascular scoring balloon catheters to treat cardiovascular and peripheral artery disease) for $230mm in up-front cash, plus contingent commercial and regulatory milestone payments.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Spectranetics acquires AngioScore
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice